Newsroom
For media inquiries, please contact 340B Health Senior Vice President of Communications Jon Tilton at jon.tilton@340bhealth.org or 202-536-2285.
-
Community HealthCare System in St. Marys to close emergency room doors, adjust services
-
HOSPITAL GROUPS SEEK ACTION ON DRUG COMPANY VIOLATIONS OF 340B LAW
-
STUDY DEMONSTRATES HOW DRUG COMPANY CUTS TO 340B SAVINGS THREATEN VITAL SERVICES AND PATIENT HEALTH OUTCOMES
-
MAJORITY OF U.S. HOUSE BACKS EFFORTS TO PROTECT 340B FROM UNLAWFUL DRUG COMPANY ACTIONS
-
STATEMENT ON COURT DISMISSAL OF 340B COMMUNITY PHARMACY LAWSUIT
-
340B HOSPITALS ARE INTEGRAL TO THE EFFORT TO PURSUE HEALTH EQUITY
-
STATEMENT ON NEW DRUG COMPANY LAWSUITS TARGETING THE 340B PROGRAM
-
340B HEALTH AND ALLIES DEMAND THAT MANUFACTURERS DISCONTINUE ILLEGAL DRUG PRICING PRACTICES
-
340B HEALTH BOARD ELECTS TWO NEW MEMBERS
-
Eli Lilly, other Big Pharma firms are making it harder for low-income patients to get discount drugs under federal program, doctors say
-
STATEMENT ON HHS GENERAL COUNSEL’S ADVISORY OPINION ON 340B CONTRACT PHARMACIES
-
Drug Makers Are Pulling Back From a Program to Help the Needy